• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌的免疫微环境

Immune Microenvironment of Thyroid Cancer.

作者信息

Yin Hongyu, Tang Yemei, Guo Yujia, Wen Shuxin

机构信息

Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, Shanxi Medical University, Taiyuan 030001, Shanxi, P.R. China.

Department of Otolaryngology Head & Neck Surgery, The First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, P.R. China.

出版信息

J Cancer. 2020 Jun 8;11(16):4884-4896. doi: 10.7150/jca.44506. eCollection 2020.

DOI:10.7150/jca.44506
PMID:32626535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7330689/
Abstract

Thyroid cancer (TC) is a highly heterogeneous endocrine malignancy with an increased incidence in women than in men. Previous studies regarding the pathogenesis of TC focused on the pathological changes of the tumor cells while ignoring the importance of the mesenchymal cells in tumor microenvironment. However, more recently, the stable environment provided by the interaction of thyroid cancer cells with the peri-tumoral stroma has been widely studied. Studies have shown that components of an individual's immune system are closely related to the occurrence, invasion, and metastasis of TC, which may affect response to treatment and prognosis of the patients. This article presents a comprehensive review of the immune cells, secreted soluble mediators and immune checkpoints in the immune microenvironment, mechanisms that promoting TC cells immune evasion and existing immunotherapy strategies. Besides it provides new strategies for TC prognosis prediction and immunotherapy.

摘要

甲状腺癌(TC)是一种高度异质性的内分泌恶性肿瘤,女性发病率高于男性。以往关于TC发病机制的研究主要集中在肿瘤细胞的病理变化上,而忽视了肿瘤微环境中间质细胞的重要性。然而,最近,甲状腺癌细胞与肿瘤周围基质相互作用所提供的稳定环境受到了广泛研究。研究表明,个体免疫系统的组成部分与TC的发生、侵袭和转移密切相关,这可能会影响患者的治疗反应和预后。本文全面综述了免疫微环境中的免疫细胞、分泌的可溶性介质和免疫检查点,促进TC细胞免疫逃逸的机制以及现有的免疫治疗策略。此外,它还为TC的预后预测和免疫治疗提供了新的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b688/7330689/2090b36f3853/jcav11p4884g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b688/7330689/2090b36f3853/jcav11p4884g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b688/7330689/2090b36f3853/jcav11p4884g001.jpg

相似文献

1
Immune Microenvironment of Thyroid Cancer.甲状腺癌的免疫微环境
J Cancer. 2020 Jun 8;11(16):4884-4896. doi: 10.7150/jca.44506. eCollection 2020.
2
Crosstalk between Thyroid Carcinoma and Tumor-Correlated Immune Cells in the Tumor Microenvironment.甲状腺癌与肿瘤微环境中肿瘤相关免疫细胞之间的串扰
Cancers (Basel). 2023 May 22;15(10):2863. doi: 10.3390/cancers15102863.
3
Harnessing Immunity to Treat Advanced Thyroid Cancer.利用免疫疗法治疗晚期甲状腺癌。
Vaccines (Basel). 2023 Dec 30;12(1):45. doi: 10.3390/vaccines12010045.
4
The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer.甲状腺癌中的肿瘤微环境与雌激素循环
Cancers (Basel). 2023 Apr 25;15(9):2458. doi: 10.3390/cancers15092458.
5
Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?间充质基质细胞(MSCs)与结直肠癌:抗肿瘤免疫反应中的一对麻烦搭档?
Oncotarget. 2016 Sep 13;7(37):60752-60774. doi: 10.18632/oncotarget.11354.
6
Current and future immunotherapies for thyroid cancer.甲状腺癌的当前和未来免疫疗法。
Expert Rev Anticancer Ther. 2018 Feb;18(2):149-159. doi: 10.1080/14737140.2018.1417845. Epub 2017 Dec 22.
7
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine.胆管癌的免疫微环境:从分子发病机制到精准医学。
J Autoimmun. 2019 Jun;100:17-26. doi: 10.1016/j.jaut.2019.03.007. Epub 2019 Mar 9.
8
The role of the tumour microenvironment in immunotherapy.肿瘤微环境在免疫治疗中的作用。
Endocr Relat Cancer. 2017 Dec;24(12):T283-T295. doi: 10.1530/ERC-17-0146. Epub 2017 Jul 28.
9
The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.肿瘤血管在宿主免疫反应中的作用:对靶向肿瘤微环境的治疗策略的启示。
Front Immunol. 2016 Dec 20;7:621. doi: 10.3389/fimmu.2016.00621. eCollection 2016.
10
Cancer immunotherapy: the art of targeting the tumor immune microenvironment.癌症免疫疗法:靶向肿瘤免疫微环境的艺术。
Cancer Chemother Pharmacol. 2019 Aug;84(2):227-240. doi: 10.1007/s00280-019-03894-3. Epub 2019 Jun 25.

引用本文的文献

1
Papillary Thyroid Carcinoma and Body Mass Index: The Role of Immune System in Tumor Microenvironment.甲状腺乳头状癌与体重指数:免疫系统在肿瘤微环境中的作用
Int J Mol Sci. 2025 Aug 26;26(17):8290. doi: 10.3390/ijms26178290.
2
Natural Killer Cell and Extracellular Vesicle-Based Immunotherapy in Thyroid Cancer: Advances, Challenges, and Future Perspectives.基于自然杀伤细胞和细胞外囊泡的甲状腺癌免疫治疗:进展、挑战与未来展望
Cells. 2025 Jul 16;14(14):1087. doi: 10.3390/cells14141087.
3
Characteristic expression profile of small nucleolar RNAs and their association with tumor immune microenvironment in papillary thyroid carcinoma.

本文引用的文献

1
Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma.免疫相关关键基因 CLDN10 与甲状腺乳头状癌的淋巴结转移相关,但预测其预后良好。
Aging (Albany NY). 2020 Feb 11;12(3):2825-2839. doi: 10.18632/aging.102780.
2
The multifaceted anti-cancer effects of BRAF-inhibitors.BRAF抑制剂的多方面抗癌作用。
Oncotarget. 2019 Nov 12;10(61):6623-6640. doi: 10.18632/oncotarget.27304.
3
Chest wall lymph node metastasis from follicular thyroid carcinoma: a rare case report.
甲状腺乳头状癌中小核仁RNA的特征性表达谱及其与肿瘤免疫微环境的关联
BMC Cancer. 2025 Jul 1;25(1):1073. doi: 10.1186/s12885-025-14498-x.
4
HIF1A acts as target of XiHuang Pill in the treatment of papillary thyroid cancer by regulating dedifferentiation.缺氧诱导因子1α(HIF1A)作为西黄丸治疗甲状腺乳头状癌去分化的作用靶点。
Front Chem. 2025 Jun 9;13:1607067. doi: 10.3389/fchem.2025.1607067. eCollection 2025.
5
Single‑cell transcriptomic analysis revealed the tumor‑associated microenvironment of papillary thyroid carcinoma with metastasis.单细胞转录组分析揭示了伴有转移的甲状腺乳头状癌的肿瘤相关微环境。
Oncol Lett. 2025 Jan 7;29(3):130. doi: 10.3892/ol.2025.14876. eCollection 2025 Mar.
6
PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancer.PIS作为甲状腺癌中细胞异质性、预后意义及免疫格局的调节因子。
Transl Oncol. 2025 May;55:102296. doi: 10.1016/j.tranon.2025.102296. Epub 2025 Mar 24.
7
Prognostic value of EMT-related genes and immune cell infiltration in thyroid carcinoma.甲状腺癌中 EMT 相关基因和免疫细胞浸润的预后价值。
Front Immunol. 2024 Nov 4;15:1463258. doi: 10.3389/fimmu.2024.1463258. eCollection 2024.
8
Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives.分子遗传学、治疗学和 RET 抑制剂耐药性在甲状腺髓样癌中的应用及未来展望。
Cell Commun Signal. 2024 Sep 28;22(1):460. doi: 10.1186/s12964-024-01837-x.
9
Immune microenvironment in papillary thyroid carcinoma: roles of immune cells and checkpoints in disease progression and therapeutic implications.甲状腺乳头状癌的免疫微环境:免疫细胞和检查点在疾病进展中的作用及其治疗意义。
Front Immunol. 2024 Sep 3;15:1438235. doi: 10.3389/fimmu.2024.1438235. eCollection 2024.
10
The Association of Pretreatment Systemic Immune Inflammatory Response Index (SII) and Neutrophil-to-Lymphocyte Ratio (NLR) with Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma.甲状腺乳头状癌患者治疗前全身免疫炎症反应指数(SII)和中性粒细胞与淋巴细胞比值(NLR)与淋巴结转移的相关性
Int J Gen Med. 2024 Jul 1;17:2887-2897. doi: 10.2147/IJGM.S461708. eCollection 2024.
胸壁淋巴结转移滤泡状甲状腺癌:罕见病例报告。
Diagn Pathol. 2019 Nov 20;14(1):130. doi: 10.1186/s13000-019-0907-0.
4
The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes.苯乙双胍在甲状腺癌细胞系和正常甲状腺细胞中的抗癌作用。
Oncotarget. 2019 Nov 5;10(60):6432-6443. doi: 10.18632/oncotarget.27266.
5
Intratumoral Cytotoxic T-Lymphocyte Density and PD-L1 Expression Are Prognostic Biomarkers for Patients with Colorectal Cancer.肿瘤内细胞毒性T淋巴细胞密度和PD-L1表达是结直肠癌患者的预后生物标志物。
Medicina (Kaunas). 2019 Oct 31;55(11):723. doi: 10.3390/medicina55110723.
6
Tumor-associated macrophages: an accomplice in solid tumor progression.肿瘤相关巨噬细胞:实体瘤进展的帮凶。
J Biomed Sci. 2019 Oct 20;26(1):78. doi: 10.1186/s12929-019-0568-z.
7
HIF1α/PD-L1 axis mediates hypoxia-induced cell apoptosis and tumor progression in follicular thyroid carcinoma.低氧诱导因子1α/程序性死亡配体1轴介导滤泡状甲状腺癌中缺氧诱导的细胞凋亡和肿瘤进展。
Onco Targets Ther. 2019 Aug 13;12:6461-6470. doi: 10.2147/OTT.S203724. eCollection 2019.
8
NK Cell Dysfunction and Checkpoint Immunotherapy.自然杀伤细胞功能障碍与检查点免疫治疗。
Front Immunol. 2019 Aug 21;10:1999. doi: 10.3389/fimmu.2019.01999. eCollection 2019.
9
Immune and Inflammatory Cells in Thyroid Cancer Microenvironment.甲状腺癌微环境中的免疫和炎症细胞。
Int J Mol Sci. 2019 Sep 7;20(18):4413. doi: 10.3390/ijms20184413.
10
Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers.胃肠肿瘤寡转移的肿瘤生物学和多学科策略。
Semin Cancer Biol. 2020 Feb;60:334-343. doi: 10.1016/j.semcancer.2019.08.026. Epub 2019 Aug 21.